Belite Bio Inc. ADS/$BLTE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Belite Bio Inc. ADS
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
Ticker
$BLTE
Sector
Primary listing
Employees
25
Headquarters
Website
BLTE Metrics
BasicAdvanced
$2.1B
-
-$0.78
-1.50
-
Price and volume
Market cap
$2.1B
Beta
-1.5
52-week high
$74.49
52-week low
$49.00
Average daily volume
59K
Financial strength
Current ratio
23.148
Interest coverage (TTM)
-1,284.10%
Profitability
EBITDA (TTM)
-25.5
Effective tax rate (TTM)
-0.05%
Management effectiveness
Return on assets (TTM)
-11.68%
Return on equity (TTM)
-17.33%
Valuation
Price to book
14.18
Price to tangible book (TTM)
14.18
Growth
Earnings per share change (TTM)
-36.07%
3-year earnings per share growth (CAGR)
4.46%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Belite Bio Inc. ADS stock?
Belite Bio Inc. ADS (BLTE) has a market cap of $2.1B as of August 22, 2025.
What is the P/E ratio for Belite Bio Inc. ADS stock?
The price to earnings (P/E) ratio for Belite Bio Inc. ADS (BLTE) stock is 0 as of August 22, 2025.
Does Belite Bio Inc. ADS stock pay dividends?
No, Belite Bio Inc. ADS (BLTE) stock does not pay dividends to its shareholders as of August 22, 2025.
When is the next Belite Bio Inc. ADS dividend payment date?
Belite Bio Inc. ADS (BLTE) stock does not pay dividends to its shareholders.
What is the beta indicator for Belite Bio Inc. ADS?
Belite Bio Inc. ADS (BLTE) has a beta rating of -1.5. This means that it has an inverse relation to market volatility.